CLINICAL_TRIALS
ClinicalTrials.gov record update
A Composition Comprising Glucoraphanin, Myrosinase and a Buffered Solution for Use in the Treatment of Neurodegenerative Diseases
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07360977
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:35.355101+00:00
- Published At
- 2026-01-22T00:00:00+00:00
- Record Updated At
- 2026-01-22
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["PARKINSON DISEASE (Disorder)", "Multiple Sclerosis (MS) - Relapsing-remitting", "Pediatric Patients Affected by Neuromuscolar and Degenerative Diseases"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-22"- protocolSection.identificationModule.nctId
"NCT07360977"- protocolSection.identificationModule.officialTitle
"A Composition Comprising Glucoraphanin, Myrosinase and a Buffered Solution for Use in the Treatment of Neurodegenerative Diseases"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.